$0.00
(Market cap
$95 Mln
Revenue (TTM)
$10 Mln
P/E Ratio
--
P/B Ratio
7.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-3.3 %
-
ROCE
-- %
-
Industry P/E
50.52
-
EV/EBITDA
-0.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
272,843,008
10 Years Aggregate
CFO
$-495.79 Mln
EBITDA
$-371.92 Mln
Net Profit
$-841.12 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
| 9.4 | 3.1 | 41.1 | 25.0 | -45.1 | -51.4 | -39.3 |
|
BSE Sensex*
| -12.1 | -3.7 | -4.0 | -9.7 | 5.9 | 7.5 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
| -8.6 | -68.5 | 76.2 | -57.1 | -95.0 | 17.0 | 48.5 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Asensus Surgical (ASXC)
|
0.4 | 94.9 | 9.9 | -83.8 | -721.2 | -- | -- | 7.1 |
| 459.9 | 809.4 | 181.6 | 12.6 | 6.0 | 5.2 | 64.5 | 3.4 |
Shareholding Pattern
View DetailsAbout Asensus Surgical (ASXC)
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the... interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina. Read more
-
President, CEO & Director
Mr. Anthony Fernando
-
Executive VP & CFO
Mr. Shameze Rampertab B.Sc. MBA, CA, CPA
-
Headquarters
Durham, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Asensus Surgical (ASXC)
What is the current share price of Asensus Surgical Inc (ASXC) Today?
The share price of Asensus Surgical Inc (ASXC) is $0.35 (NYSE) as of 22-Aug-2024 09:30 EDT. Asensus Surgical Inc (ASXC) has given a return of -45.14% in the last 3 years.
What is the current PB & PE ratio of Asensus Surgical Inc (ASXC)?
Since, TTM earnings of Asensus Surgical Inc (ASXC) is negative, P/E ratio is not available.
The P/B ratio of Asensus Surgical Inc (ASXC) is 7.09 times as on 30-Aug-2024, a 117 premium to its peers’ median range of 3.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-1.02
|
2.39
|
|
2022
|
-1.09
|
0.83
|
|
2021
|
-4.03
|
1.49
|
|
2020
|
-0.75
|
0.72
|
|
2019
|
-0.17
|
0.48
|
What is the 52 Week High and Low of Asensus Surgical Inc (ASXC)?
The 52-week high and low of Asensus Surgical Inc (ASXC) are Rs -- and Rs -- as of 10-Jun-2026.
What is the market cap of Asensus Surgical Inc (ASXC)?
Asensus Surgical Inc (ASXC) has a market capitalisation of $ 95 Mln as on 30-Aug-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Asensus Surgical Inc (ASXC)?
Before investing in Asensus Surgical Inc (ASXC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.